SARS-CoV-2

Prakash Jadhav1, Bo Huang2, Jerzy Osipiuk3

  • 1Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.

概括

新的SARS-CoV-2抗病毒药物候选人显示出有前途. 研究人员确定了向病毒帕帕因样蛋白酶 (PLpro) 的强有力的抑制剂,这对病毒复制和免疫逃避至关重要,为抗击COVID-19提供了希望.